Skip to main content
Equibles

FMR LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 315066 BOSTON, MA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,372,493
+$4,269,727 QoQ
Shares Held
240,115
+3220.2% QoQ
Ownership
0.373%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. CGEM ranks #177 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,372,493 240,115
2026-03-31 $102,766 7,232
2025-12-31 $47,588 4,598
2025-09-30 $5,740 968
2025-06-30 $28,704 3,812
2025-03-31 $19,371 2,559
2024-12-31 $521,206 42,792
2024-09-30 $340,826 20,360
2024-06-30 $11,841 679
2024-03-31 $8,963 526
2023-12-31 $4,503 442
2023-09-30 $14,244 1,574
2023-06-30 $590,960 54,922
2023-03-31 $555,202 54,272
2022-12-31 $932,472 88,386
2022-09-30 $1,660,625 129,534
2022-06-30 $2,744,325 214,066
2022-03-31 $17,057,514 1,629,180
2021-12-31 $14,504,817 940,040
2021-09-30 $56,429,783 2,500,212
2021-06-30 $50,931,105 1,977,907
2021-03-31 $50,844,650 1,220,174